| T.ROWE US EQUITY FUND A | RVI USA | -3,26% | 46,38% | 80,92% | 180,45% |
| VANGUARD U.S. OPPORTUNITIES INSTITUTIONAL USD CAP | RVI USA | 14,09% | 63,59% | 80,92% | · |
| SCHRODER ISF QEP GLOBAL QUALITY I ACC USD | RVI GLOBAL | 5,44% | 44,78% | 80,91% | 162,87% |
| JPM US VALUE I2 (ACC) EUR | RVI USA VALOR | -2,90% | 27,97% | 80,90% | · |
| DNCA INVEST - VALUE EUROPE B EUR | RVI EUROPA VALOR | 20,03% | 58,01% | 80,89% | 69,81% |
| GOLDMAN SACHS US TECHNOLOGY OPPORTUNITIES EQUITY PORTFOLIO BASE USD CAP | TMT | -0,90% | 101,98% | 80,88% | · |
| GOLDMAN SACHS GLOBAL SMALL CAP CORE EQUITY PORTFOLIO P (SNAP) USD CAP | RVI GLOBAL SMALL/MID CAP | 7,42% | 48,49% | 80,85% | 155,28% |
| BNY MELLON U.S. EQUITY INCOME FUND USD B (INC) | RVI USA | 0,86% | 23,50% | 80,82% | · |
| AMUNDI FUNDS EUROLAND EQUITY I2 EUR (C) | RV EURO | 14,75% | 53,74% | 80,81% | · |
| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | BIOTECNOLOGÍA | 24,52% | 59,44% | 80,81% | 261,07% |
| BGF EUROPEAN EQUITY INCOME D2 USD (HEDGED) | RVI EUROPA | 3,51% | 39,03% | 80,80% | 110,23% |
| CT (LUX) US CONTRARIAN CORE EQUITIES DE EUR | RVI USA | -1,29% | 58,61% | 80,80% | · |
| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | BIOTECNOLOGÍA | 24,98% | 59,11% | 80,78% | 263,77% |
| SCHRODER ISF FRONTIER MARKETS EQUITY A DIS USD | RVI EMERGENTES | 6,24% | 47,50% | 80,78% | 74,39% |
| SCHRODER ISF GLOBAL EQUITY IZ ACC USD | RVI GLOBAL | 3,30% | 53,00% | 80,78% | · |
| CT (LUX) US CONTRARIAN CORE EQUITIES DU USD | RVI USA | -0,94% | 58,30% | 80,76% | 184,75% |
| SANTANDER GO GLOBAL EQUITY BE CAP | RVI GLOBAL | -2,01% | 50,81% | 80,76% | · |
| GOLDMAN SACHS GLOBAL CORE EQUITY PORTFOLIO BASE (SNAP) USD DIS | RVI GLOBAL | 4,73% | 59,23% | 80,75% | 162,22% |
| FIDELITY FUNDS-NORDIC A-ACC-EUR | RVI EUROPA | 24,84% | 50,27% | 80,74% | 172,71% |
| BLACKROCK SYSTEMATIC STYLE FACTOR IPF2 CHF HEDGED | GESTIÓN ALTERNATIVA | 10,41% | 43,55% | 80,72% | · |
